Expert Review of Clinical Pharmacology

Papers
(The H4-Index of Expert Review of Clinical Pharmacology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Personalizing tamoxifen therapy in adjuvant therapy: a brief summary of the ongoing discussion57
A review of current and emerging therapies in breast cancer: implications for older adults56
Renin angiotensin aldosterone inhibitors in the treatment of proteinuria in children with congenital anomalies of the kidney and urinary tract: more evidence needed41
Prostate cancer and novel pharmacological treatment options–what’s new for 2022?40
Therapeutic drug monitoring of antiretroviral therapy: current progresses and future directions40
Sparsentan: a dual endothelin and angiotensin II receptor antagonist approved for IgA nephropathy39
Reducing the risk of death – a possible outcome in COPD patients39
Strategies for lowering lipoprotein(a): a spotlight on novel pharmacological treatments36
A simulation study to assess the influence of population pharmacokinetic model selection on Bayesian forecasting of vancomycin exposure in preterm neonates35
Practical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies32
Sodium-glucose cotransporter 2 inhibitors in frail, older people with type 2 diabetes and heart failure: do we have enough evidence to confidently support the use?31
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review30
Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria30
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome30
Effects of the augmentation with quetiapine or olanzapine on the metabolism of duloxetine: a retrospective analysis27
Management of polypharmacy through deprescribing in older patients: a review of the role of AI tools25
What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion24
Clinical pharmacology of antiplatelet drugs24
Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis23
Amylin analogs for the treatment of obesity without diabetes: present and future23
Clinical efficacy and safety of topical difamilast in the treatment of patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials22
Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy22
0.13795399665833